Ann: Positive IHL-675A in vivo results and FDA Pathway, page-112

Hi MM,
I think there is little doubt that psychedelics is going to be a game changer for IHL.
It would be really good for IHL to come out and give us some details of their plan/strategy in relation to the development and commercialisation of their psychedelics program.
Taking on Dr Paul Liknaitsky is a fair clue of their intention to exploit the psychedelics market, but some confirmation in terms of a formal announcement would be huge.